Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Genentech, Gilead, GSK, Merck, Novartis and Sanofi have agreed to drug pricing deals.

Even when Americans have health insurance, they can have a hard time affording the drugs they've been prescribed.

Pharmacy cost management is one of the toughest challenges employers will face in 2026, according to new data from Employee ...

The commonwealth claims that pharmacy benefit managers and drug manufacturers are in cahoots to inflate insulin prices for ...

Patient and Provider Protection Act would address the rising cost of prescription drugs by establishing requirements for ...

Millions of Medicare Part D enrollees will see substantial out-of-pocket savings as negotiated drug prices take effect in ...

Listen to this article Rising costs and the growing demand for health care are challenging patients, doctors, businesses, health insurers, and the entire health care system. These trends are causing ...

Pets bring joy and companionship to two-thirds of U.S. households. But that benefit may not extend to their owners’ wallets. Just like humans, these canine and feline friends need medical care. In a ...

Here are five ways AARP has fought to make lower drug prices a top priority. The 2003 law that created Medicare Part D ...